OBJECTIVE: Maternal immune activation (MIA) triggered by infections has been identified as a cause of autism in offspring. Considering the involvement of perturbations in innate immunity in epilepsy, we examined whether MIA represents a risk factor for epilepsy as well. The role of specific MIA components interleukin (IL)-6 and IL-1β was also addressed. METHODS: MIA was induced in C57BL/6 mice by polyinosinic-polycytidylic acid (PIC) injected during embryonic days 12 to 16. Beginning from postnatal day 40, the propensity of the offspring to epilepsy was examined using hippocampal kindling; autismlike behavior was studied using the sociability test. The involvement of IL-6 and IL-1β in PIC-induced effects was studied by the coadministration of the cytokine antibodies with PIC, and by delivering recombinant cytokines in lieu of PIC. RESULTS: The offspring of PIC-exposed mice exhibited increased hippocampal excitability, accelerated kindling rate, prolonged increase of seizure susceptibility after kindling, and diminished sociability. Epileptic impairments were abolished by antibodies to IL-6 or IL-1β. Neither of the recombinant cytokines alone increased the propensity to seizures; however, when combined, they produced effects similar to those induced by PIC. PIC-induced behavioral deficits were abolished by IL-6 antibodies and were mimicked by recombinant IL-6; IL-1β was not involved. INTERPRETATION: In addition to confirming the previously established critical role of IL-6 in the development of autismlike behavior following MIA, the present study shows that concurrent involvement of IL-6 and IL-1β is required for priming the offspring for epilepsy. These data shed light on mechanisms of comorbidity between autism and epilepsy.
OBJECTIVE: Maternal immune activation (MIA) triggered by infections has been identified as a cause of autism in offspring. Considering the involvement of perturbations in innate immunity in epilepsy, we examined whether MIA represents a risk factor for epilepsy as well. The role of specific MIA components interleukin (IL)-6 and IL-1β was also addressed. METHODS: MIA was induced in C57BL/6 mice by polyinosinic-polycytidylic acid (PIC) injected during embryonic days 12 to 16. Beginning from postnatal day 40, the propensity of the offspring to epilepsy was examined using hippocampal kindling; autismlike behavior was studied using the sociability test. The involvement of IL-6 and IL-1β in PIC-induced effects was studied by the coadministration of the cytokine antibodies with PIC, and by delivering recombinant cytokines in lieu of PIC. RESULTS: The offspring of PIC-exposed mice exhibited increased hippocampal excitability, accelerated kindling rate, prolonged increase of seizure susceptibility after kindling, and diminished sociability. Epileptic impairments were abolished by antibodies to IL-6 or IL-1β. Neither of the recombinant cytokines alone increased the propensity to seizures; however, when combined, they produced effects similar to those induced by PIC. PIC-induced behavioral deficits were abolished by IL-6 antibodies and were mimicked by recombinant IL-6; IL-1β was not involved. INTERPRETATION: In addition to confirming the previously established critical role of IL-6 in the development of autismlike behavior following MIA, the present study shows that concurrent involvement of IL-6 and IL-1β is required for priming the offspring for epilepsy. These data shed light on mechanisms of comorbidity between autism and epilepsy.
Authors: J J Nadler; S S Moy; G Dold; D Trang; N Simmons; A Perez; N B Young; R P Barbaro; J Piven; T R Magnuson; J N Crawley Journal: Genes Brain Behav Date: 2004-10 Impact factor: 3.449
Authors: A Vezzani; D Moneta; M Conti; C Richichi; T Ravizza; A De Luigi; M G De Simoni; G Sperk; S Andell-Jonsson; J Lundkvist; K Iverfeldt; T Bartfai Journal: Proc Natl Acad Sci U S A Date: 2000-10-10 Impact factor: 11.205
Authors: B Viviani; S Bartesaghi; F Gardoni; A Vezzani; M M Behrens; T Bartfai; M Binaglia; E Corsini; M Di Luca; C L Galli; M Marinovich Journal: J Neurosci Date: 2003-09-24 Impact factor: 6.167
Authors: Irene Knuesel; Laurie Chicha; Markus Britschgi; Scott A Schobel; Michael Bodmer; Jessica A Hellings; Stephen Toovey; Eric P Prinssen Journal: Nat Rev Neurol Date: 2014-10-14 Impact factor: 42.937
Authors: Mohamed A El-Missiry; Azza I Othman; Maher A Amer; Mohammed Sedki; Sara M Ali; Ibrahim M El-Sherbiny Journal: Metab Brain Dis Date: 2019-11-14 Impact factor: 3.584
Authors: Stephen T Vito; Adam T Austin; Christopher N Banks; Bora Inceoglu; Donald A Bruun; Dorota Zolkowska; Daniel J Tancredi; Michael A Rogawski; Bruce D Hammock; Pamela J Lein Journal: Toxicol Appl Pharmacol Date: 2014-10-14 Impact factor: 4.219